Patent Assignment
Reel/Frame 066128/0069
Merger
Recorded: 2023-12-26
Pages: 9
Assignor
PROTIVA BIOTHERAPEUTICS, INC.
Executed: 2018-01-01
Assignee
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Property
(1)
Targeted Nucleic Acid Conjugate Compositions
Related Assignments
(1)
Other recorded transfers of the patent in this record — the chain of ownership.